0
     

Report Added
Report already added
Hepatitis B Vaccines Market - Global Outlook and Forecast 2021-2027

Hepatitis B Vaccines Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Hepatitis B Vaccines in global, including the following market information:
Global Hepatitis B Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Hepatitis B Vaccines Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Hepatitis B Vaccines companies in 2020 (%)
The global Hepatitis B Vaccines market was valued at 1034 million in 2020 and is projected to reach US$ 1107.1 million by 2027, at a CAGR of 1.7% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis B Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, By Type, 2020 (%)
Yeast Derived
CHO Derived

Global Hepatitis B Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, By Application, 2020 (%)
Children
Adult

Global Hepatitis B Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Hepatitis B Vaccines revenues share in global market, 2020 (%)
Key companies Hepatitis B Vaccines sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Hepatitis B Vaccines sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Vaccines Overall Market Size
2.1 Global Hepatitis B Vaccines Market Size: 2021 VS 2027
2.2 Global Hepatitis B Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Hepatitis B Vaccines Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Hepatitis B Vaccines Players in Global Market
3.2 Top Global Hepatitis B Vaccines Companies Ranked by Revenue
3.3 Global Hepatitis B Vaccines Revenue by Companies
3.4 Global Hepatitis B Vaccines Sales by Companies
3.5 Global Hepatitis B Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hepatitis B Vaccines Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Hepatitis B Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis B Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis B Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B Vaccines Market Size Markets, 2021 & 2027
4.1.2 Yeast Derived
4.1.3 CHO Derived
4.2 By Type - Global Hepatitis B Vaccines Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Vaccines Revenue, 2016-2021
4.2.2 By Type - Global Hepatitis B Vaccines Revenue, 2022-2027
4.2.3 By Type - Global Hepatitis B Vaccines Revenue Market Share, 2016-2027
4.3 By Type - Global Hepatitis B Vaccines Sales & Forecasts
4.3.1 By Type - Global Hepatitis B Vaccines Sales, 2016-2021
4.3.2 By Type - Global Hepatitis B Vaccines Sales, 2022-2027
4.3.3 By Type - Global Hepatitis B Vaccines Sales Market Share, 2016-2027
4.4 By Type - Global Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Vaccines Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Hepatitis B Vaccines Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Vaccines Revenue, 2016-2021
5.2.2 By Application - Global Hepatitis B Vaccines Revenue, 2022-2027
5.2.3 By Application - Global Hepatitis B Vaccines Revenue Market Share, 2016-2027
5.3 By Application - Global Hepatitis B Vaccines Sales & Forecasts
5.3.1 By Application - Global Hepatitis B Vaccines Sales, 2016-2021
5.3.2 By Application - Global Hepatitis B Vaccines Sales, 2022-2027
5.3.3 By Application - Global Hepatitis B Vaccines Sales Market Share, 2016-2027
5.4 By Application - Global Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Hepatitis B Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Hepatitis B Vaccines Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Vaccines Revenue, 2016-2021
6.2.2 By Region - Global Hepatitis B Vaccines Revenue, 2022-2027
6.2.3 By Region - Global Hepatitis B Vaccines Revenue Market Share, 2016-2027
6.3 By Region - Global Hepatitis B Vaccines Sales & Forecasts
6.3.1 By Region - Global Hepatitis B Vaccines Sales, 2016-2021
6.3.2 By Region - Global Hepatitis B Vaccines Sales, 2022-2027
6.3.3 By Region - Global Hepatitis B Vaccines Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Hepatitis B Vaccines Revenue, 2016-2027
6.4.2 By Country - North America Hepatitis B Vaccines Sales, 2016-2027
6.4.3 US Hepatitis B Vaccines Market Size, 2016-2027
6.4.4 Canada Hepatitis B Vaccines Market Size, 2016-2027
6.4.5 Mexico Hepatitis B Vaccines Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Hepatitis B Vaccines Revenue, 2016-2027
6.5.2 By Country - Europe Hepatitis B Vaccines Sales, 2016-2027
6.5.3 Germany Hepatitis B Vaccines Market Size, 2016-2027
6.5.4 France Hepatitis B Vaccines Market Size, 2016-2027
6.5.5 U.K. Hepatitis B Vaccines Market Size, 2016-2027
6.5.6 Italy Hepatitis B Vaccines Market Size, 2016-2027
6.5.7 Russia Hepatitis B Vaccines Market Size, 2016-2027
6.5.8 Nordic Countries Hepatitis B Vaccines Market Size, 2016-2027
6.5.9 Benelux Hepatitis B Vaccines Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Hepatitis B Vaccines Revenue, 2016-2027
6.6.2 By Region - Asia Hepatitis B Vaccines Sales, 2016-2027
6.6.3 China Hepatitis B Vaccines Market Size, 2016-2027
6.6.4 Japan Hepatitis B Vaccines Market Size, 2016-2027
6.6.5 South Korea Hepatitis B Vaccines Market Size, 2016-2027
6.6.6 Southeast Asia Hepatitis B Vaccines Market Size, 2016-2027
6.6.7 India Hepatitis B Vaccines Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Hepatitis B Vaccines Revenue, 2016-2027
6.7.2 By Country - South America Hepatitis B Vaccines Sales, 2016-2027
6.7.3 Brazil Hepatitis B Vaccines Market Size, 2016-2027
6.7.4 Argentina Hepatitis B Vaccines Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis B Vaccines Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Hepatitis B Vaccines Sales, 2016-2027
6.8.3 Turkey Hepatitis B Vaccines Market Size, 2016-2027
6.8.4 Israel Hepatitis B Vaccines Market Size, 2016-2027
6.8.5 Saudi Arabia Hepatitis B Vaccines Market Size, 2016-2027
6.8.6 UAE Hepatitis B Vaccines Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis B Vaccines Major Product Offerings
7.1.4 GSK Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.1.5 GSK Key News
7.2 NCPC
7.2.1 NCPC Corporate Summary
7.2.2 NCPC Business Overview
7.2.3 NCPC Hepatitis B Vaccines Major Product Offerings
7.2.4 NCPC Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.2.5 NCPC Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Hepatitis B Vaccines Major Product Offerings
7.3.4 Merck Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 Bio Kangtai
7.4.1 Bio Kangtai Corporate Summary
7.4.2 Bio Kangtai Business Overview
7.4.3 Bio Kangtai Hepatitis B Vaccines Major Product Offerings
7.4.4 Bio Kangtai Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.4.5 Bio Kangtai Key News
7.5 Dynavax
7.5.1 Dynavax Corporate Summary
7.5.2 Dynavax Business Overview
7.5.3 Dynavax Hepatitis B Vaccines Major Product Offerings
7.5.4 Dynavax Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.5.5 Dynavax Key News
7.6 Hissen
7.6.1 Hissen Corporate Summary
7.6.2 Hissen Business Overview
7.6.3 Hissen Hepatitis B Vaccines Major Product Offerings
7.6.4 Hissen Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.6.5 Hissen Key News
7.7 KM Biologics
7.7.1 KM Biologics Corporate Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis B Vaccines Major Product Offerings
7.4.4 KM Biologics Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.7.5 KM Biologics Key News
7.8 LG Life Sciences
7.8.1 LG Life Sciences Corporate Summary
7.8.2 LG Life Sciences Business Overview
7.8.3 LG Life Sciences Hepatitis B Vaccines Major Product Offerings
7.8.4 LG Life Sciences Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.8.5 LG Life Sciences Key News
7.9 Serum Institute
7.9.1 Serum Institute Corporate Summary
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Hepatitis B Vaccines Major Product Offerings
7.9.4 Serum Institute Hepatitis B Vaccines Sales and Revenue in Global (2016-2021)
7.9.5 Serum Institute Key News
8 Global Hepatitis B Vaccines Production Capacity, Analysis
8.1 Global Hepatitis B Vaccines Production Capacity, 2016-2027
8.2 Hepatitis B Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis B Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis B Vaccines Supply Chain Analysis
10.1 Hepatitis B Vaccines Industry Value Chain
10.2 Hepatitis B Vaccines Upstream Market
10.3 Hepatitis B Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis B Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hepatitis B Vaccines in Global Market
Table 2. Top Hepatitis B Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Hepatitis B Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Hepatitis B Vaccines Revenue Share by Companies, 2016-2021
Table 5. Global Hepatitis B Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. Global Hepatitis B Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hepatitis B Vaccines Price (2016-2021) & (USD/Doses)
Table 8. Global Manufacturers Hepatitis B Vaccines Product Type
Table 9. List of Global Tier 1 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hepatitis B Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Hepatitis B Vaccines Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Hepatitis B Vaccines Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Hepatitis B Vaccines Sales (M Doses), 2016-2021
Table 15. By Type - Global Hepatitis B Vaccines Sales (M Doses), 2022-2027
Table 16. By Application – Global Hepatitis B Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Hepatitis B Vaccines Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Hepatitis B Vaccines Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Hepatitis B Vaccines Sales (M Doses), 2016-2021
Table 20. By Application - Global Hepatitis B Vaccines Sales (M Doses), 2022-2027
Table 21. By Region – Global Hepatitis B Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Hepatitis B Vaccines Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Hepatitis B Vaccines Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Hepatitis B Vaccines Sales (M Doses), 2016-2021
Table 25. By Region - Global Hepatitis B Vaccines Sales (M Doses), 2022-2027
Table 26. By Country - North America Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Hepatitis B Vaccines Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Hepatitis B Vaccines Sales, (M Doses), 2016-2021
Table 29. By Country - North America Hepatitis B Vaccines Sales, (M Doses), 2022-2027
Table 30. By Country - Europe Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Hepatitis B Vaccines Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Hepatitis B Vaccines Sales, (M Doses), 2016-2021
Table 33. By Country - Europe Hepatitis B Vaccines Sales, (M Doses), 2022-2027
Table 34. By Region - Asia Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Hepatitis B Vaccines Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Hepatitis B Vaccines Sales, (M Doses), 2016-2021
Table 37. By Region - Asia Hepatitis B Vaccines Sales, (M Doses), 2022-2027
Table 38. By Country - South America Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Hepatitis B Vaccines Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Hepatitis B Vaccines Sales, (M Doses), 2016-2021
Table 41. By Country - South America Hepatitis B Vaccines Sales, (M Doses), 2022-2027
Table 42. By Country - Middle East & Africa Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Hepatitis B Vaccines Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Hepatitis B Vaccines Sales, (M Doses), 2016-2021
Table 45. By Country - Middle East & Africa Hepatitis B Vaccines Sales, (M Doses), 2022-2027
Table 46. GSK Corporate Summary
Table 47. GSK Hepatitis B Vaccines Product Offerings
Table 48. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 49. NCPC Corporate Summary
Table 50. NCPC Hepatitis B Vaccines Product Offerings
Table 51. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 52. Merck Corporate Summary
Table 53. Merck Hepatitis B Vaccines Product Offerings
Table 54. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 55. Bio Kangtai Corporate Summary
Table 56. Bio Kangtai Hepatitis B Vaccines Product Offerings
Table 57. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 58. Dynavax Corporate Summary
Table 59. Dynavax Hepatitis B Vaccines Product Offerings
Table 60. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 61. Hissen Corporate Summary
Table 62. Hissen Hepatitis B Vaccines Product Offerings
Table 63. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 64. KM Biologics Corporate Summary
Table 65. KM Biologics Hepatitis B Vaccines Product Offerings
Table 66. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 67. LG Life Sciences Corporate Summary
Table 68. LG Life Sciences Hepatitis B Vaccines Product Offerings
Table 69. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 70. Serum Institute Corporate Summary
Table 71. Serum Institute Hepatitis B Vaccines Product Offerings
Table 72. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 73. Hepatitis B Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2019-2021 (M Doses)
Table 74. Global Hepatitis B Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Global Hepatitis B Vaccines Production by Region, 2016-2021 (M Doses)
Table 76. Global Hepatitis B Vaccines Production by Region, 2022-2027 (M Doses)
Table 77. Hepatitis B Vaccines Market Opportunities & Trends in Global Market
Table 78. Hepatitis B Vaccines Market Drivers in Global Market
Table 79. Hepatitis B Vaccines Market Restraints in Global Market
Table 80. Hepatitis B Vaccines Raw Materials
Table 81. Hepatitis B Vaccines Raw Materials Suppliers in Global Market
Table 82. Typical Hepatitis B Vaccines Downstream
Table 83. Hepatitis B Vaccines Downstream Clients in Global Market
Table 84. Hepatitis B Vaccines Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Hepatitis B Vaccines Segment by Type
Figure 2. Hepatitis B Vaccines Segment by Application
Figure 3. Global Hepatitis B Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hepatitis B Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Hepatitis B Vaccines Sales in Global Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Vaccines Revenue in 2020
Figure 9. By Type - Global Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 10. By Type - Global Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 11. By Type - Global Hepatitis B Vaccines Price (USD/Doses), 2016-2027
Figure 12. By Application - Global Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 13. By Application - Global Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 14. By Application - Global Hepatitis B Vaccines Price (USD/Doses), 2016-2027
Figure 15. By Region - Global Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 16. By Region - Global Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 17. By Country - North America Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 18. By Country - North America Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 19. US Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 24. Germany Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 25. France Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 33. China Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 37. India Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 39. By Country - South America Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 40. Brazil Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Hepatitis B Vaccines Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Hepatitis B Vaccines Sales Market Share, 2016-2027
Figure 44. Turkey Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Hepatitis B Vaccines Revenue, (US$, Mn), 2016-2027
Figure 48. Global Hepatitis B Vaccines Production Capacity (M Doses), 2016-2027
Figure 49. The Percentage of Production Hepatitis B Vaccines by Region, 2020 VS 2027
Figure 50. Hepatitis B Vaccines Industry Value Chain
Figure 51. Marketing Channels

Report Title: Hepatitis B Vaccines Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW